International Prospective REgistry on Pre-pectorAl Breast REconstruction | MicrobiomeTrials← Back to trialsNCT05817175
International Prospective REgistry on Pre-pectorAl Breast REconstruction
RecruitingOBSERVATIONAL
Trial Details
Start: 2023-09-12Est. Completion: 2028-12-15
Enrollment target: 1,236 participants Locations- Univesidad de Buenos Aires, Buenos Aires, Argentina
- Mansoura Insurance, Al Mansurah, Egypt
- Mansoura Oncology, Al Mansurah, Egypt
- National ans Kapodistrian University of Athens, Athens, Greece
- Ospedale San Raffaele, Milan, MI, Italy
- Fondazione Policlinico Universitario Agostino Gemelli, Roma, RM, Italy
- University Hospital of Karol Marcinkowski, Zielona Góra, Poland
- Prof. Dr. Ion Chiricuta Institute of Oncology, Cluj-Napoca, Romania
- Hospital del Mar, Barcelona, Spain
- Marmara University School of medicine, Istanbul, Turkey (Türkiye)
- University Hospitals of Leicester, Leicester, United Kingdom
Other microbiome trials you might be interested in
Triple-Negative Breast Cancer
This is a randomized, open-label study comparing the efficacy and safety of adjuvant sacituzumab tirumotecan (MK-2870) i…
Mobile, United StatesEst. completion Dec 16, 2030
BREAST CANCER
A PROSPECTIVE, MULTI-CENTER, PHASE 4, SINGLE ARM STUDY TO ASSESS THE SAFETY OF TRASTUZUMAB DERUXTECAN, AN ANTI-HER2-ANTI…
Bangalore, IndiaEst. completion Oct 31, 2026
Recruiting
In this study, a randomized controlled study was conducted between two groups of 40 recipients of conventional flap duri…
Busan, South KoreaEst. completion Jun 30, 2024